• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $SNYR

    Synergy CHC Corp.

    Subscribe to $SNYR
    $SNYR
    Other Pharmaceuticals
    Health Care

    IPO Year: 2024

    Exchange: NASDAQ

    Recent Analyst Ratings for Synergy CHC Corp.

    DatePrice TargetRatingAnalyst
    1/21/2025$10.00Buy
    ROTH MKM
    See more ratings

    Synergy CHC Corp. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ROTH MKM initiated coverage on Synergy CHC Corp. with a new price target

      ROTH MKM initiated coverage of Synergy CHC Corp. with a rating of Buy and set a new price target of $10.00

      1/21/25 9:10:17 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care

    Synergy CHC Corp. Leadership Updates

    Live Leadership Updates

    See more
    • Synergy CHC Announces Appointment of Erik Shields as Vice President of Beverage

      WESTBROOK, Maine, May 29, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that Erik Shields has been named Vice President of Beverage of Synergy, effective May 26, 2025. "We're excited to welcome Erik to the team and look forward to his contributions," said Jack Ross, CEO of Synergy. "With nearly two decades of experience leading national strategies, managing key accounts, and building high-performance teams, Erik brings the leadership and executional expertise needed to help scale our beverage business. As we focus on accelerating growth in this category, we're confident he w

      5/29/25 8:00:00 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care

    Synergy CHC Corp. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more

    Synergy CHC Corp. SEC Filings

    See more
    • CEO and Chairman Ross Jack bought $10,870 worth of shares (5,300 units at $2.05), increasing direct ownership by 1% to 366,507 units (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      5/21/25 5:05:31 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • CEO and Chairman Ross Jack bought $39,350 worth of shares (14,340 units at $2.74), increasing direct ownership by 4% to 361,207 units (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      5/21/25 4:46:18 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • CEO and Chairman Ross Jack bought $59,521 worth of shares (15,200 units at $3.92), increasing direct ownership by 5% to 346,877 units (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      3/3/25 9:25:39 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • CEO and Chairman Ross Jack bought $25,460 worth of shares (5,170 units at $4.92), increasing direct ownership by 2% to 331,677 units (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      3/3/25 8:50:43 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • CEO and Chairman Ross Jack bought $2,700,000 worth of shares (300,000 units at $9.00) (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      10/24/24 7:01:13 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • SEC Form 10-Q filed by Synergy CHC Corp.

      10-Q - Synergy CHC Corp. (0001562733) (Filer)

      5/15/25 8:05:55 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Synergy CHC Corp. (0001562733) (Filer)

      5/15/25 8:00:17 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • SEC Form DEFA14A filed by Synergy CHC Corp.

      DEFA14A - Synergy CHC Corp. (0001562733) (Filer)

      4/28/25 4:20:08 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • SEC Form DEF 14A filed by Synergy CHC Corp.

      DEF 14A - Synergy CHC Corp. (0001562733) (Filer)

      4/28/25 4:16:21 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • SEC Form PRE 14A filed by Synergy CHC Corp.

      PRE 14A - Synergy CHC Corp. (0001562733) (Filer)

      4/17/25 4:15:36 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • SEC Form 10-K filed by Synergy CHC Corp.

      10-K - Synergy CHC Corp. (0001562733) (Filer)

      3/31/25 4:10:25 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

      8-K - Synergy CHC Corp. (0001562733) (Filer)

      3/31/25 8:26:06 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • SEC Form 10-Q filed by Synergy CHC Corp.

      10-Q - Synergy CHC Corp. (0001562733) (Filer)

      12/6/24 4:05:25 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. filed SEC Form 8-K: Leadership Update

      8-K - Synergy CHC Corp. (0001562733) (Filer)

      12/6/24 8:34:05 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Synergy CHC Corp. (0001562733) (Filer)

      12/6/24 8:31:00 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care

    Synergy CHC Corp. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Synergy CHC Announces Appointment of Erik Shields as Vice President of Beverage

      WESTBROOK, Maine, May 29, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that Erik Shields has been named Vice President of Beverage of Synergy, effective May 26, 2025. "We're excited to welcome Erik to the team and look forward to his contributions," said Jack Ross, CEO of Synergy. "With nearly two decades of experience leading national strategies, managing key accounts, and building high-performance teams, Erik brings the leadership and executional expertise needed to help scale our beverage business. As we focus on accelerating growth in this category, we're confident he w

      5/29/25 8:00:00 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp Reports Growth in Earnings Per Share for its First Quarter 2025 Financial Results and its Ninth Consecutive Quarter of Profitability

      WESTBROOK, Maine, May 15, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, is announcing its financial results for the three months ended March 31, 2025. "We are very pleased to report 30% growth in earnings per share year-over-year, marking our ninth consecutive quarter of profitability," said Jack Ross, CEO of Synergy. "Additionally, we expanded our EBITDA margins significantly to 24.1% compared to 19.7% in the prior year period. This performance highlights the strength of our operating model and our ongoing discipline around cost management." "We continue to make meaningful progress toward

      5/15/25 8:00:00 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. Announces First Quarter 2025 Earnings and Conference Call Information

      WESTBROOK, Maine, May 01, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that it plans to release financial results for the first quarter ended March 31, 2025, on Thursday, May 15, 2025, before the open of market trading. In conjunction with reporting first quarter 2025 results, Synergy will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT with the Company's Chief Executive Officer, Jack Ross, and the Company's Chief Financial Officer, Jaime Fickett. A live webcast of the call will be available on the Investor Relations section of Synergy's website. To access the call by

      5/1/25 4:05:00 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Reports its Eighth Consecutive Quarter of Profitability and its Fourth Quarter and Full Year 2024 Financial Results

      WESTBROOK, Maine, March 31, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, is announcing its financial results for the three and twelve months ended December 31, 2024. "We are pleased to report another fantastic year. We had another full year of profitability, marking our eighth consecutive profitable quarter—a testament to the continued strength of our business and the progress we achieved throughout 2024," said Jack Ross, CEO of Synergy. "While our fourth quarter results were still impacted by retailer de-inventorying from our FOCUSfactor packaging transition, we saw sequential improvement

      3/31/25 8:00:00 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. Announces Fourth Quarter and Full Year 2024 Earnings and Conference Call Information

      WESTBROOK, Maine, March 20, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that it plans to release financial results for the fourth quarter and full year ended December 31, 2024, on Monday, March 31, 2025, before the open of market trading. In conjunction with reporting fourth quarter and full year 2024 results, Synergy will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT with the Company's Chief Executive Officer, Jack Ross, and the Company's Chief Financial Officer, Jaime Fickett. A live webcast of the call will be available on the Investor Relations section of Syner

      3/20/25 4:05:00 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC to Attend 37th Annual ROTH Conference

      WESTBROOK, Maine, March 03, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that it will attend the 37th Annual ROTH Conference, March 16-18, 2025, in Dana Point, California. Synergy management will be available for one-on-one investor meetings. To request a meeting, please contact your ROTH sales representative. About Synergy CHC Corp. Synergy CHC Corp. is a provider of consumer health care and lifestyle products. Synergy's current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically-tested brain health supplement that has been shown to improve memory,

      3/3/25 4:05:00 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Reports its Seventh Consecutive Quarter of Profitability and its Third Quarter 2024 Financial Results

      WESTBROOK, Maine, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today its financial results for the three months ended September 30, 2024. "We are excited to announce our seventh straight quarter of profitability and to officially be listed on NASDAQ (SNYR) as a public company, marking a significant milestone for Synergy," said Jack Ross, CEO of Synergy. "This not only brings us increased liquidity but also enhances our ability to execute our long-term growth strategy, positioning us well to capitalize on the opportunities ahead. While our third quarter results were imp

      12/6/24 8:00:00 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. Announces Third Quarter 2024 Earnings and Conference Call Information

      WESTBROOK, Maine, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that it plans to release financial results for the third quarter ended September 30, 2024, on Friday, December 6, 2024, before the open of market trading. In conjunction with reporting third quarter 2024 results, Synergy will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT with the Company's Chief Executive Officer, Jack Ross, and the Company's Chief Financial Officer, Stacy Bieber. A live webcast of the call will be available on the Investor Relations section of Synergy's website. To access the c

      11/26/24 4:05:00 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. Announces Closing of Initial Public Offering

      WESTBROOK, Maine, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy"), a provider of consumer health care, beauty, and lifestyle products, announced today the completion of its initial public offering of 1,150,000 shares of its common stock at $9.00 per share. The shares of common stock began trading on the Nasdaq Global Market on October 23, 2024 under the ticker symbol "SNYR." In addition, Synergy granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of common stock at the public offering price less underwriting discounts and commissions. The net proceeds received by Synergy from the offering (after deducting underwriting disco

      10/24/24 5:00:00 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care

    Synergy CHC Corp. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by Synergy CHC Corp.

      SC 13D - Synergy CHC Corp. (0001562733) (Subject)

      10/31/24 9:55:58 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G filed by Synergy CHC Corp.

      SC 13G - Synergy CHC Corp. (0001562733) (Subject)

      10/25/24 7:46:44 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care

    Synergy CHC Corp. Financials

    Live finance-specific insights

    See more

    Synergy CHC Corp. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Synergy CHC Corp Reports Growth in Earnings Per Share for its First Quarter 2025 Financial Results and its Ninth Consecutive Quarter of Profitability

      WESTBROOK, Maine, May 15, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, is announcing its financial results for the three months ended March 31, 2025. "We are very pleased to report 30% growth in earnings per share year-over-year, marking our ninth consecutive quarter of profitability," said Jack Ross, CEO of Synergy. "Additionally, we expanded our EBITDA margins significantly to 24.1% compared to 19.7% in the prior year period. This performance highlights the strength of our operating model and our ongoing discipline around cost management." "We continue to make meaningful progress toward

      5/15/25 8:00:00 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. Announces First Quarter 2025 Earnings and Conference Call Information

      WESTBROOK, Maine, May 01, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that it plans to release financial results for the first quarter ended March 31, 2025, on Thursday, May 15, 2025, before the open of market trading. In conjunction with reporting first quarter 2025 results, Synergy will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT with the Company's Chief Executive Officer, Jack Ross, and the Company's Chief Financial Officer, Jaime Fickett. A live webcast of the call will be available on the Investor Relations section of Synergy's website. To access the call by

      5/1/25 4:05:00 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. Announces Fourth Quarter and Full Year 2024 Earnings and Conference Call Information

      WESTBROOK, Maine, March 20, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that it plans to release financial results for the fourth quarter and full year ended December 31, 2024, on Monday, March 31, 2025, before the open of market trading. In conjunction with reporting fourth quarter and full year 2024 results, Synergy will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT with the Company's Chief Executive Officer, Jack Ross, and the Company's Chief Financial Officer, Jaime Fickett. A live webcast of the call will be available on the Investor Relations section of Syner

      3/20/25 4:05:00 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. Announces Third Quarter 2024 Earnings and Conference Call Information

      WESTBROOK, Maine, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that it plans to release financial results for the third quarter ended September 30, 2024, on Friday, December 6, 2024, before the open of market trading. In conjunction with reporting third quarter 2024 results, Synergy will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT with the Company's Chief Executive Officer, Jack Ross, and the Company's Chief Financial Officer, Stacy Bieber. A live webcast of the call will be available on the Investor Relations section of Synergy's website. To access the c

      11/26/24 4:05:00 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • CEO and Chairman Ross Jack bought $10,870 worth of shares (5,300 units at $2.05), increasing direct ownership by 1% to 366,507 units (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      5/21/25 5:05:31 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • CEO and Chairman Ross Jack bought $39,350 worth of shares (14,340 units at $2.74), increasing direct ownership by 4% to 361,207 units (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      5/21/25 4:46:18 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • CEO and Chairman Ross Jack bought $59,521 worth of shares (15,200 units at $3.92), increasing direct ownership by 5% to 346,877 units (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      3/3/25 9:25:39 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • CEO and Chairman Ross Jack bought $25,460 worth of shares (5,170 units at $4.92), increasing direct ownership by 2% to 331,677 units (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      3/3/25 8:50:43 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • CEO and Chairman Ross Jack bought $2,700,000 worth of shares (300,000 units at $9.00) (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      10/24/24 7:01:13 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care